Home >Current Issue

Volume: 9, Issue: 7, July, 2019
DOI: 10.7324/JAPS.2019.90710



Research Article

Initiation of pharmacist–psychiatrist collaborative patient education in ambulatory care settings of a tertiary care teaching hospital in south India

Sai Krishna Gudi1, Ambed Mishra1, Tony David Kurian1, Sravani Alla1, Justin Kurian1, Madhan Ramesh1, Kishor Manohar Rao2

  Author Affiliations


Abstract

The aim of this study is to initiate the pharmacist–psychiatrist collaborative patient education in ambulatory care settings. A prospective cohort study was conducted in psychiatry out-patient department of a tertiary care teaching hospital over a period of 6 months. All the eligible patients were enrolled, and the necessary information was collected. The collected data were analyzed for medication adherence by using medication adherence rating scale and health-related quality of life by using the World Health Organization Quality of Life questionnaire. Student t-test was used to analyze the results at p-value

Keywords:

Quality of life, medication adherence, pharmacist– psychiatrist collaborative care, ambulatory care.



Citation: Gudi SK, Mishra A, Kurian TD, Alla S, Kurian J, Ramesh M, Kishor M. Initiation of pharmacist–psychiatrist collaborative patient education in ambulatory care settings of a tertiary care teaching hospital in south India. J Appl Pharm Sci, 2019; 9(07):078–081.


Copyright: The Author(s). This is an open access article distributed under the Creative Commons Attribution Non-Commercial License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

References

Aronson JK. "Collaborative care" is preferable to "patient centred care". BMJ, 2016; 353:i2926. https://doi.org/10.1136/bmj.i2926

Chisholm-Burns M, Kim Lee J, Spivey C, Slack M, Herrier R, Hall-Lipsy E, Graff Zivin J, Abraham I, Palmer J, Martin JR, Kramer SS, Wunz T. US pharmacistsʼ effect as team members on patient care. Med Care, 2010; 48(10):923-33. https://doi.org/10.1097/MLR.0b013e3181e57962

Fox A, Reeves S. Inter-professional collaborative patient-centred care: a critical exploration of two related discourses. J Interprof Care, 2015; 29(2):113-8. https://doi.org/10.3109/13561820.2014.954284

Galuppi A, Turola MC, Nanni MG, Mazzoni P, Grassi L. Schizophrenia and quality of life: how important are symptoms and functioning. Int J Ment Health Syst, 2010; 4(3):2-8. https://doi.org/10.1186/1752-4458-4-31

Happell B, Manias E, Roper C. Wanting to be heard: mental health consumers' experiences of information about medication. Int J Ment Health Nurs, 2004; 13(4):242-8. https://doi.org/10.1111/j.1440-0979.2004.00340.x

Kelly D, Bishop L, Young S, Hawboldt J, Phillips L, Keough T. Pharmacist and physician views on collaborative practice: Findings from the community pharmaceutical care project. Can Pharm J, 2013; 146(4):218-26. https://doi.org/10.1177/1715163513492642

Kucukarslan S, Lai S, Dong Y, Al-Bassam N, Kim K. Physician beliefs and attitudes toward collaboration with community pharmacists. Res Soc Admin Pharm, 2011; 7:224-32. https://doi.org/10.1016/j.sapharm.2010.07.003

Maslen C, Rees L, Redfern P. Role of the community pharmacist in the care of patients with chronic schizophrenia in the community. Int J Pharm Pract, 1996; 4(4):187-95. https://doi.org/10.1111/j.2042-7174.1996.tb00867.x

Melo-Neto VL, Valenca AM, Nascimento I, Lopes FL, Nardi AE. Quality of life assessment by WHOQOL-BREF in panic disorder patients during treatment. Rev Psiq Clín, 2008; 35(2):49-54. https://doi.org/10.1590/S0101-60832008000200002

Mishra A, Krishna GS, Alla S, Kurian TD, Kurian J, Ramesh M, Kishor M. Impact of pharmacist-psychiatrist collaborative patient education on medication adherence and quality of life (QOL) of bipolar affective disorder (BPAD) patients. Front Pharmacol, 2017; 8:722; doi:10.3389/ fphar.2017.00722 https://doi.org/10.3389/fphar.2017.00722

Mishra A, Krishna GS, Sravani A, Kurian TD, Kurian J, Ramesh M, Kishor M. Impact of pharmacist-led collaborative patient education on medication adherence and quality of life of schizophrenia patients in a tertiary care setting. Bull Fac Pharm Cairo Univ, 2017; 55(2):345-9. https://doi.org/10.1016/j.bfopcu.2017.08.001

Nichols J. Pharmacist scope of practice. Ann Intern Med, 2002; 136(4):W2. https://doi.org/10.7326/0003-4819-136-4-200202190-w2

OfforI Enato E. Patients' assessment of pharmacists' medication counseling in a psychiatric hospital in Nigeria. Trop J Pharm Res, 2011; 10(4):507-16. https://doi.org/10.4314/tjpr.v10i4.17

Ormel J, Petukhova M, Chatterji S, Aguilar-Gaxiola S, Alonso J, Angermeyer M, Bromet EJ, Burger H, Demyttenaere K, de Girolamo G, Haro JM, Hwang I, Karam E, Kawakami N, Lépine JP, Medina-Mora ME, Posada-Villa J, Sampson N, Scott K, Ustün TB, Von Korff M, Williams DR, Zhang M, Kessler RC. Disability and treatment of specific mental and physical disorders across the world. Br J Psychiatr, 2008; 192(5):368-75. https://doi.org/10.1192/bjp.bp.107.039107

Parthasarthi G, Karin N-H, Nahata MC. Clinical pharmacy in India. A textbook of clinical pharmacy practice, vol. 1. Universities Press, Hyderabad, India, pp 1-8, 2004.

Phokeo V, Sproule B, Raman-Wilms L. Community pharmacists' attitudes toward and professional interactions with users of psychiatric medication. Int J Soc Psychiatr, 2004; 55(12):1434-6. https://doi.org/10.1176/appi.ps.55.12.1434

Rathert C, Wyrwich MD, Boren SA. Patient-centered care and outcomes: a systematic review of the literature. Med Care Res Rev, 2013; 70(4):351-79. https://doi.org/10.1177/1077558712465774

Stoner S, Ott C, DiPaula B. Psychiatric pharmacy residency training. Am J Pharm Educ, 2010; 74(9):163. https://doi.org/10.5688/aj7409163

Thakkar KB, Jain MM, Billa G, Joshi A, Khobragade AA. A drug utilization study of psychotropic drugs prescribed in the psychiatry outpatient department of a tertiary care hospital. J Clin Diagn Res, 2013; 7(12):2759-64. https://doi.org/10.7860/JCDR/2013/6760.3885

The WHOQOL Group. Development of the World Health Organization WHOQOL-BREF Quality of Life Assessment. Psychol Med, 1998; 28:551;8. https://doi.org/10.1017/S0033291798006667

Thompson K, Kulkarni J, Sergejew AA. Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophr Res, 2000; 42:24100 https://doi.org/10.1016/S0920-9964(99)00130-9

Article Metrics

Similar Articles

Development of a Predictor Model for Quality of Life in Cancer Patients with Adverse Drug Reactions due to Cancer Chemotherapy
Smita Khandelwal, Laxminarayana Kurady Bairy, M. S.Vidyasagar, Asha Kamath, James Gonsalves, Bharti Chogtu

Blood pressure control in hypertensive patients: impact of an Egyptian pharmaceutical care model
Abdel-Hameed I. M. Ebid, Zina T. Ali and Mohamed A.F.Ghobary